Formulations and clinical trial materials lead Piramal's new Ahmedabad facility

Piramal Pharma Solutions is on schedule to commission a new state of the art formulations development and clinical trial materials (CTM) supply centre at Ahmedabad, India. The centre will have GMP supply capabilities from March onwards.

Piramal Pharma Solutions is on schedule to commission a new state of the art formulations development and clinical trial materials (CTM) supply centre at Ahmedabad, India. The centre will have GMP supply capabilities from March onwards.

Located in Ahmedabad's Special Export Promotion (SEZ) Zone, the centre has a total footprint of 50,000ft2, of which half will be built out in Phase I. Initially, more than 34 formulators and 48 analytical chemists will be based at the centre - with plans to increase to a total of 180 over two phases.

The facility will provide the full suite of services, including formulations development, analytical development and validation, CTM supply, exhibit batches and ICH stability studies. It is equipped with state of the art, instrumented equipment for early phase solids formulations development and CTM supply.

Ten GMP suites with dedicated air handling units will allow work simultaneously on several projects. Separate suites are being built out with "Low RH" capability as well as ability to handle high potency actives.

"The latest development in Ahmedabad signals the continuing upgrade in our clinical trials manufacturing and services capabilities," said Dr R. Ananthanarayanan, president and head for Piramal Pharma Solutions. "The programme marks further expansion of our synthesis-to-market supply chain, with further elements due for announcement later this year."

Featured Companies

Piramal Pharma Solutions (more information, website)